OneSavings Bank, Fat Face, Saga – as much as market chatter amplifies regarding a slow down of the IPO main market, issuers seem to be pushing it forward with momentum.
And it’s not just London’s main market that’s keeping dealmakers busy. According to the latest data pieced together by Adviser Rankings, the Aim market picked up pace month-on-month during the last quarter of the 2013/14 financial year.
March witnessed 12 new admissions, an uptick of 50 per cent on February’s figures, and twice as many as the total number of admissions in January.
Meanwhile, the pharma deals frenzy continues, with a raft of US firms including Fried Frank, Sullivan & Cromwell and Cleary stepping up to the plate for Bayer’s $14.2bn acquisition of Merck’s consumer care division.
Also on TheLawyer.com
- DLA Piper has hired private equity partner Tim Wright from King & Wood Mallesons SJ Berwin
- Clydesdale Bank has launched its first panel review since overhauling its legal team in 2012
- Lawrence Graham loses its corporate finance head Christopher Tite to Wedlake Bell, alongside real estate partner Louise Gowman
Banking – Wragge Lawrence Graham & Co: Wealth management and asset management sectors: what you should be aware of in FCA’s Business Plan 2
Company – Khaitan & Co: RBI notifies foreign direct investment in limited liability partnerships
Finance – Stephenson Harwood: Intercontinental Exchange Benchmark Administration: the new administrator of LIBOR
Funds – Stephenson Harwood: ATHEX: the place of opportunities
Company – NCTM: Minibonds: regulation following the new provisions of law